May Measurement Month 2021: an analysis of blood pressure screening results from Ghana
Author(s)
Type
Journal Article
Abstract
May Measurement Month (MMM) is a global campaign initiated by the International Society of Hypertension (ISH) with the aim of raising awareness of high blood pressure (BP) and serving as a catalyst for the establishment of screening programmes around the world. An opportunistic cross-sectional survey of volunteers aged ≥18 years was conducted. A standardized protocol for MMM was used to measure BP and collect relevant health information from participants at screening sites in four regions of Ghana. Hypertension was defined as a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or on antihypertensive medication. A total of 4832 people agreed to take part in the MMM21 study and were screened. After multiple imputation of missing BP readings, 1426 people (29.5%) had hypertension. 11.9% of the 1426 participants with hypertension were aware of their condition, and 8.6% reported taking antihypertensive medication. 24.2% of 123 people on antihypertensive medication had their BP under control (<140/90 mmHg). In addition, only 2.1% of the 1426 participants with hypertension had controlled BP. Results from this study found that almost nine out of 10 people with hypertension who were screened were unaware of their condition, most were untreated, and only 2% of those with hypertension had their BP controlled with medication. This emphasizes the importance of BP screening campaigns as a tool for identifying and referring people with high BP for treatment.
Date Issued
2024-06
Date Acceptance
2024-07-01
Citation
European Heart Journal Supplements, 2024, 26 (Supplement 3), pp.iii38-iii40
ISSN
1520-765X
Publisher
Oxford University Press
Start Page
iii38
End Page
iii40
Journal / Book Title
European Heart Journal Supplements
Volume
26
Issue
Supplement 3
Copyright Statement
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://
creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for
reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for
further information please contact journals.permissions@oup.com.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://
creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for
reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for
further information please contact journals.permissions@oup.com.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/39055579
Subjects
Blood pressure
Control
Hypertension
Screening. Treatment
Publication Status
Published
Coverage Spatial
England
Article Number
suae047
Date Publish Online
2024-07-24